A detailed history of Abel Hall, LLC transactions in Organon & Co. stock. As of the latest transaction made, Abel Hall, LLC holds 11,121 shares of OGN stock, worth $175,711. This represents 0.16% of its overall portfolio holdings.

Number of Shares
11,121
Previous 11,014 0.97%
Holding current value
$175,711
Previous $207 Million 11.18%
% of portfolio
0.16%
Previous 0.15%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$17.45 - $21.96 $1,867 - $2,349
107 Added 0.97%
11,121 $230 Million
Q1 2024

May 08, 2024

BUY
$13.78 - $18.8 $151,772 - $207,063
11,014 New
11,014 $207 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.02B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Abel Hall, LLC Portfolio

Follow Abel Hall, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abel Hall, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abel Hall, LLC with notifications on news.